PharmD, MSc R&D Portfolio Strategy, UCB Biopharma, Joined UCB in 2015
Mata Charokopou, PharmD, leads the strategy and management of UCB’s development portfolio, overseeing assets from candidate selection through to their establishment as established brands. She is responsible for portfolio-wide strategic planning, prioritization, and resource allocation across the R&D pipeline. With a focus on maximizing portfolio value and ensuring alignment with corporate objectives, Mata works closely with Portfolio Board and R&D governance to drive data-informed decisions and optimize asset progression from early clinical development through late-stage execution. Prior this role, Mata led the Global Access and Pricing strategy Unit of UCB and led the launch Strategy of the immunology portfolio for UCB’s regional cluster of South-East Europe.
Education
Mata graduated from the University of Patras, Greece, in 2010, with a first-class Doctor of Pharmacy degree. She received a Master of Science in Health Economics, Policy & Law from the Erasmus University of Rotterdam, the Netherlands, in 2011.
